{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T14:22:49Z","timestamp":1792765369839,"version":"4.5.0"},"reference-count":13,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2011,5,17]],"date-time":"2011-05-17T00:00:00Z","timestamp":1305590400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Public Health"],"published-print":{"date-parts":[[2011,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Background<\/jats:title>\n            <jats:p>Passively acquired maternal antibodies are necessary to protect infants against circulating measles virus until they reach the eligible age of vaccination. Likewise, high levels of population immunity must be achieved and maintained to reduce measles virus transmission. This study was undertaken to (1) assess the presence of maternally acquired measles-specific IgG antibodies among infants less than 9 months of age in Bangui, Central African Republic and (2) determine the immune status of vaccination-age children and the concordance with reported vaccination status. A secondary objective was to describe the presence of rubella-specific IgG antibody in the study population.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods<\/jats:title>\n            <jats:p>Vaccination history and blood samples were collected from 395 children using blotting paper. Samples were analyzed for the presence of measles-specific IgG antibodies using commercial ELISA kits.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>Measles-specific IgG antibodies were detected in 51.3% of vaccinated children and 27.6% of non-vaccinated children. Maternally derived measles IgG antibodies were present in only 14.8% of infants aged 0-3 months and were absent in all infants aged 4-8 months. The presence of IgG-specific measles antibodies varied among children of vaccination age, from 57.3% for children aged 9 months to 5 years, to 50.6% for children aged 6-9 years and 45.6% for chidren aged 10 years and above. The overall prevalence of rubella-specific IgG was 55.4%, with a high prevalence (87.4%) among children over 10 years of age.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusion<\/jats:title>\n            <jats:p>The findings suggest that despite efforts to accelerate measles control by giving a second dose of measles vaccine, a large number of children remain susceptible to measles virus. Further research is required to determine the geographic extent of immunity gaps and the factors that influence immunity to measles virus in the Central African Republic.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1186\/1471-2458-11-327","type":"journal-article","created":{"date-parts":[[2011,6,11]],"date-time":"2011-06-11T06:23:44Z","timestamp":1307773424000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":18,"title":["Seroprevalence of measles and natural rubella antibodies among children in Bangui, Central African Republic"],"prefix":"10.1186","volume":"11","author":[{"given":"Alexandre","family":"Manirakiza","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean Marie","family":"Kipela","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen","family":"Sosler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R\u00e9gis M'Bary","family":"Daba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ionela","family":"Gouandjika-Vasilache","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2011,5,17]]},"reference":[{"issue":"84","key":"3094_CR1","first-page":"349","volume":"35","author":"WHO","year":"2009","unstructured":"WHO: Measles vaccines: WHO position paper. Weekly Epidemiol Rec. 2009, 35 (84): 349-360.","journal-title":"Weekly Epidemiol Rec"},{"key":"3094_CR2","volume-title":"Country Profiles and International Human Development Indicators","author":"HDR","year":"2010","unstructured":"HDR: Country Profiles and International Human Development Indicators. 2010, [http:\/\/hdrstats.undp.org\/en\/countries\/profiles\/CAF.html]"},{"key":"3094_CR3","volume-title":"Millennium Development Goals Indicators","author":"United., Nations","year":"2010","unstructured":"United., Nations: Millennium Development Goals Indicators. 2010, [http:\/\/mdgs.un.org\/unsd\/mdg\/Default.aspx]"},{"key":"3094_CR4","first-page":"264","volume-title":"Loss of maternal measles antibody during infancy in an African city","author":"F Dabis","year":"1989","unstructured":"Dabis F, Waldman RJ, Mann GF, Commenges D, Madzou G, Jones TS: Loss of maternal measles antibody during infancy in an African city. 1989, IEA, 18: 264-"},{"key":"3094_CR5","first-page":"29","volume-title":"Disparition des anticorps antirougeoleux d'origine maternelle chez le nourrisson gabonais = Disappearing of antimeasles antibodies of maternal origine in the gabonese infant","author":"D Gendrel","year":"1987","unstructured":"Gendrel D, Engohan E, Gendrel C, Makanga MT, Garin D, Moussavou A, Xueref C, Ajjan N: Disparition des anticorps antirougeoleux d'origine maternelle chez le nourrisson gabonais = Disappearing of antimeasles antibodies of maternal origine in the gabonese infant. 1987, SOPEMI, 34: 29-32."},{"key":"3094_CR6","first-page":"544","volume-title":"Response to measles vaccine in Haitian infants 6 to 12 months old","author":"NA Halsey","year":"1985","unstructured":"Halsey NA, Boulos R, Mode F, Andre J, Bowman L, Yaeger RG, Toureau S, Rohde J, Boulos C: Response to measles vaccine in Haitian infants 6 to 12 months old. 1985, Massachusetts Medical Society, 313: 544-549."},{"key":"3094_CR7","first-page":"635","volume-title":"Placental transfer and decay of maternally acquired antimeasles antibodies in Nigerian children","author":"HK Hartter","year":"2000","unstructured":"Hartter HK, Oyedele OI, Dietz K, Kreis S, Hoffman JP, Muller CP: Placental transfer and decay of maternally acquired antimeasles antibodies in Nigerian children. 2000, 19: 635-"},{"key":"3094_CR8","first-page":"684","volume-title":"Prevalence of IgG antibody against measles, mumps and rubella in Bangladeshi children: a pilot study to evaluate the need for integrated vaccination strategy","author":"R Sultana","year":"2006","unstructured":"Sultana R, Rahman MM, Hassan Z, Hassan MS: Prevalence of IgG antibody against measles, mumps and rubella in Bangladeshi children: a pilot study to evaluate the need for integrated vaccination strategy. 2006, Wiley Online Library, 64: 684-689."},{"key":"3094_CR9","first-page":"26","volume-title":"A serosurvey to identify the window of vulnerability to wild-type measles among infants in rural Mali","author":"MD Tapia","year":"2005","unstructured":"Tapia MD, Sow SO, Medina-Moreno S, Lim Y, Pasetti MF, Kotloff K, Levine MM: A serosurvey to identify the window of vulnerability to wild-type measles among infants in rural Mali. 2005, ASTMH, 73: 26-"},{"key":"3094_CR10","volume-title":"WHO UNICEF Joint Reporting Form data; WHO UNICEF Best Estimates","author":"WHO","year":"2010","unstructured":"WHO: WHO UNICEF Joint Reporting Form data; WHO UNICEF Best Estimates. 2010, [http:\/\/www.who.int\/immunization_monitoring\/data\/data_subject\/en\/index.html]"},{"issue":"2","key":"3094_CR11","first-page":"59","volume":"19","author":"BJ Okoko","year":"2001","unstructured":"Okoko BJ, Wesuperuma LH, Ota MO, Banya WA, Pinder M, Gomez FS, Osinusi K, Hart AC: Influence of placental malaria infection and maternal hypergammaglobulinaemia on materno-foetal transfer of measles and tetanus antibodies in a rural west African population. J Health Popul Nutr. 2001, 19 (2): 59-65.","journal-title":"J Health Popul Nutr"},{"key":"3094_CR12","volume-title":"Enqu\u00eate \u00e0 indicateurs multiples coupl\u00e9e avec la s\u00e9rologie VIH et an\u00e9mie en RCA, 2006","author":"MICSS-RCA","year":"2010","unstructured":"MICSS-RCA: Enqu\u00eate \u00e0 indicateurs multiples coupl\u00e9e avec la s\u00e9rologie VIH et an\u00e9mie en RCA, 2006. 2010, [http:\/\/www.unicef.org\/infobycountry\/car_statistics.html]"},{"key":"3094_CR13","volume-title":"Global Acute Malnutrition","author":"UNICEF","year":"2010","unstructured":"UNICEF: Global Acute Malnutrition. 2010, [http:\/\/www.unicef.org\/infobycountry\/media_50744.html]"}],"container-title":["BMC Public Health"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2458-11-327.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/1471-2458-11-327\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2458-11-327","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2458-11-327.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T13:59:16Z","timestamp":1630504756000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcpublichealth.biomedcentral.com\/articles\/10.1186\/1471-2458-11-327"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,5,17]]},"references-count":13,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2011,12]]}},"alternative-id":["3094"],"URL":"https:\/\/doi.org\/10.1186\/1471-2458-11-327","relation":{},"ISSN":["1471-2458"],"issn-type":[{"value":"1471-2458","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,5,17]]},"assertion":[{"value":"5 November 2010","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 May 2011","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 May 2011","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"327"}}